Economic Atlas
Companies/PAVmed Inc.
Company profile

PAVmed Inc.

NASDAQ: PAVM · Healthcare · Medical - Devices
PublicHQ New York City, NY · New YorkCIK 0001624326Reports USD
#1066 of 1,422 Healthcare companies by revenuebottom-decile growth
EA Score
40D
Revenue TTM
$85.0k
Rev growth YoY (TTM)
-95.7%
Net income (FY)
$401.0k
Employees
41
as of 2026-08-24
Market cap
$33.0M
as of 2026-08-24

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$71.0k$71.0k2025
Net income$401.0k$401.0k2025
Operating income-$21.8M-$21.8M2025
Total assets$38.8M$38.8M2025
Liabilities$16.5M$16.5M2025
Equity$34.0M$34.0M2025

Revenue trend

FY2021 – FY2025 · USD
FY21
FY22
FY23
FY24
FY25

Revenue by segment

Filed disclosures · FY2022
By product
Royalty100%
By geography

Not disclosed.

The read

What is PAVmed Inc.’s revenue?

PAVmed Inc. booked $71.0k in FY2025 revenue, contracting 98% year over year — among the slowest-growing Healthcare companies we track, at a 564.8% net margin.

Peers · Healthcare
Silo Pharma, Inc.39DIMAC Holdings, Inc.——Paranovus Entertainment Technology Ltd.——Exlites Holdings International, Inc.54DeXoZymes, Inc.24DOncotelic Therapeutics, Inc.46D
Neighbors
New York →
JPMorgan Chase & Co.$182.4B72BMorgan Stanley$34.3B61CThe Goldman Sachs Group, Inc.——Philip Morris International Inc.$40.6B86AAmerican Express Company$41.3B78B+Citigroup Inc.$85.2B55C
Key facts
CEOLishan Aklog
SectorHealthcare
IndustryMedical - Devices
HeadquartersNew York City, NY
ExchangeNASDAQ: PAVM
Employees41
IPO date2016-07-27
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.